$67.940
+1.583 (+2.33%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BBIO Prediction & Forecast by Similar Chart Analysis
Alphio's BBIO stock price prediction model matches the current BridgeBio Pharma, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $68.76 (+1.20%). The 1-week path is $68.78 (+1.23%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy BridgeBio Pharma, Inc. Stock?
BridgeBio Pharma Inc is a good buy right now due to its current price of $66.39, which is significantly lower than the analyst price targets ranging from $94 to $157. The company has shown a gross margin of 93.83% in Q2 2026, indicating strong profitability potential. Additionally, the recent partnership with the U.S. government to enhance drug access could drive future revenue growth. However, the main risk is the negative net income, which was -$155,891,000 in Q2 2026, indicating ongoing financial challenges that investors should monitor closely.
BBIO stock price ended at $67.94 on Monday, after rising +2.33%
BridgeBio Pharma, Inc. (BBIO) last closed at $67.94, gaining +2.33%. These facts feed the 1-day and 1-week BBIO price prediction above.
Forecast Drivers
BridgeBio Pharma, Inc. (BBIO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BBIO, ranked by similarity.
Seasonality analysis for BBIO
Historically the probability of a positive October return for BBIO is 38.33%. August offers the highest probability of a positive month at 62.50%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BBIO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $42.99 | $49.52 | $49.80 | -27.12% |
| Nov 2026 | $55.17 | $56.66 | $60.27 | -16.60% |
| Dec 2026 | $54.39 | $62.38 | $75.53 | -8.18% |
In 2026, BridgeBio Pharma, Inc. (BBIO) is projected to range from $42.99 to $75.53.
BridgeBio Pharma, Inc. 2026 monthly forecast
In Oct 2026, BridgeBio Pharma, Inc. is projected to average $49.52, with a low of $42.99 and high of $49.80.
In Nov 2026, BridgeBio Pharma, Inc. is projected to average $56.66, with a low of $55.17 and high of $60.27.
In Dec 2026, BridgeBio Pharma, Inc. is projected to average $62.38, with a low of $54.39 and high of $75.53.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.